miR-143–3p specifically inhibits SOX5 by recognizing the target sequence of SOX5 mRNA 3’-UTR in NSCLC cell lines, thereby inhibiting EMT in NSCLC (130). Here, SOX5 is linked to non-small cell lung carcinoma.